U.S. Physical Therapy Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" U.S. Physical Therapy stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USPH, but not buy additional shares or sell existing shares.
View analyst ratings for U.S. Physical Therapy or view top-rated stocks.

Wall Street analysts have given U.S. Physical Therapy a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but U.S. Physical Therapy wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for U.S. Physical Therapy.

U.S. Physical Therapy will be holding an earnings conference call on Thursday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings data on Thursday, February, 25th. The company reported $0.85 EPS for the quarter, topping the Zacks' consensus estimate of $0.83 by $0.02. The company earned $117.47 million during the quarter, compared to analyst estimates of $118.08 million. U.S. Physical Therapy had a net margin of 7.21% and a trailing twelve-month return on equity of 11.20%.
View U.S. Physical Therapy's earnings history.

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, USPH shares have increased by 17.9% and is now trading at $109.94.
View which stocks have been most impacted by COVID-19.

U.S. Physical Therapy declared a quarterly dividend on Friday, February 26th. Stockholders of record on Friday, March 12th will be given a dividend of $0.35 per share on Friday, April 9th. This represents a $1.40 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date of this dividend is Thursday, March 11th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.32.
View U.S. Physical Therapy's dividend history.

U.S. Physical Therapy pays an annual dividend of $1.40 per share and currently has a dividend yield of 1.27%. U.S. Physical Therapy does not yet have a strock track record of dividend growth. The dividend payout ratio of U.S. Physical Therapy is 49.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 46.98% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

U.S. Physical Therapy updated its FY21 earnings guidance on Thursday, February, 25th. The company provided earnings per share (EPS) guidance of $2.40-2.52 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.00.

2 analysts have issued 1 year price objectives for U.S. Physical Therapy's stock. Their forecasts range from $100.00 to $100.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $100.00 in the next twelve months. This suggests that the stock has a possible downside of 9.0%.
View analysts' price targets for U.S. Physical Therapy or view top-rated stocks among Wall Street analysts.

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Tenet Healthcare (THC), Acadia Healthcare (ACHC), Petco Health and Wellness (WOOF), The Ensign Group (ENSG), Select Medical (SEM), Community Health Systems (CYH), Brookdale Senior Living (BKD), National HealthCare (NHC), Five Star Senior Living (FVE), Capital Senior Living (CSU) and Encompass Health (EHC).
View all of USPH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

U.S. Physical Therapy's stock is owned by a number of institutional and retail investors. Top institutional investors include Scout Investments Inc. (0.80%), Fenimore Asset Management Inc. (0.59%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.04%) and Everence Capital Management Inc. (0.02%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy.

USPH stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Louisiana State Employees Retirement System. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Edward L Kuntz, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy or view top insider-selling stocks.

USPH stock was acquired by a variety of institutional investors in the last quarter, including Scout Investments Inc., Fenimore Asset Management Inc., and Everence Capital Management Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy or or view top insider-buying stocks.

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of USPH stock can currently be purchased for approximately $109.94.

U.S. Physical Therapy has a market capitalization of $1.42 billion and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis.

U.S. Physical Therapy employs 2,550 workers across the globe.

The official website for U.S. Physical Therapy is www.usph.com.

U.S. Physical Therapy is headquartered at 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042.

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]